Trial Profile
Ulinastatin for the prevention of pulmonary ischaemia in patients undergoing type-A aortic dissection after cardiopulmonary bypass under deep hypothermic circulatory arrest
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2013
Price :
$35
*
At a glance
- Drugs Ulinastatin (Primary)
- Indications Perioperative ischaemia
- Focus Pharmacodynamics; Therapeutic Use
- 09 Nov 2013 New trial record